nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL11—nasal cavity cancer	0.262	0.262	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.221	0.221	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.175	0.175	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.134	0.134	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0755	0.0755	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0686	0.0686	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL11—nasal cavity cancer	0.0405	0.0405	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FRS2—nasal cavity cancer	0.0239	0.0239	CbGpPWpGaD
